Candao, Dhen .
HRN: 21-44-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2024
MUPIROCIN 2%, 15G (TUBE)
10/02/2024
10/09/2024
TOPICAL
15 G
BID
Multiple Soft Tissue Injury, SP Closed Reduction Of Zygomatic Bone
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes